secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001104659-24-064675
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals underwriters exercise overallotment, purchase 91,050 shares at $3.30
--------------------------------------------------------------------------------

- Underwriters exercised option to buy 91,050 additional shares at $3.30 per share from previously announced offering.
- Gross proceeds from overallotment approximately $300,465; closed May 23, 2024.
- Overallotment exercise completed; shares issued at same price as initial public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/0001104659-24-064675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/tm2415394d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-064675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer